Matthew Dolan
MD
Education
Massachusetts Institute for Technology, SB, 1981Dartmouth Medical School, MD, 1985
Residency, Internal Medicine, Wilford Hall, 1988
Chief of Medical Residents, Wilford Hall, 1989
Fellowship, Infectious Diseases, Wilford Hall, 1991
Biography
Matt Dolan grew up in Flint, Michigan, and worked as an assembly line worker for Chevrolet and as an employee of the Flint Water Department before attending MIT. He graduated early from MIT, and worked as a staff scientist at the Basel Institute for Immunology before attending Medical School at Dartmouth. His military career included time at Wilford Hall USAF Medical Center as the chief of infectious disease, SAMMC infectious disease fellowship program director and Air Force consultant (specialty leader) in infectious diseases. He oversaw a virology and immunology lab there, where collaborative work led to a role as a guest speaker on NPR "Science Friday". Operational work at the start of the Iraq war on the WMD investigation was recognized with a bronze star by the Army, and 2 subsequent rotations in Iraq at the request of the White House. Subsequently as Director of the Defense Institute for Medical Operations, Dolan led work in global health training and education abroad which he continues today as a civilian. He worked for the HJF/ NIAID Phidisa program in South Africa for 7 years, developing research in HIV and TB, and leading weekly case management calls with South African military and contract physicians.Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications
Master, American College of Physicians
Fellow, Infectious Diseases Society of the Americas
Outstanding Science and Engineering Educator, Air Force Association
Bronze Star Medal, US Army
Humanitarian Service Medal, US Navy
Gold Headed Cane Award, Wilford Hall
James Leonard Award for teaching, USUHS
"Clinical Grandmaster" special experience identifier, Air Force
Laurate Award, American College of Physicians
Medicine Staff Teaching Award, Wilford Hall
Representative Bibliography
Gonzalez et al, The influence of CCL3L1 gene contIning segmental duplicationson HIV-1/AIDS Susceptibility. Science 307: 1434-40, 2005
Dolan et al, CCL3L1 and CCR-5 influence cell-mediated immunity and affect HIV pathogenesis via viral entry-independent mechanisms. Nature Immunology 8:1324-1336, 2007
ENCORE-1 Study Group, Efficacy of 400mg effavirenz vs standard 600 mg dosein HIV-infected, antiretroviral-naive adults (ENCORE-1). Lancet 383: 1474-1482, 2014
INSIGHT START Study Group, initiation of antiretroviral therapy in early, asymptomatic HIV infection. New England Journal of medicine 373: 795-807, 2015